Header Logo

Connection

Bruce Fireman to Pneumococcal Infections

This is a "connection" page, showing publications Bruce Fireman has written about Pneumococcal Infections.
Connection Strength

1.176
  1. Impact of the use of heptavalent pneumococcal conjugate vaccine on disease epidemiology in children and adults. Vaccine. 2006 Apr 12; 24 Suppl 2:S2-79-80.
    View in: PubMed
    Score: 0.262
  2. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J. 2004 Jun; 23(6):485-9.
    View in: PubMed
    Score: 0.230
  3. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003 Jan; 22(1):10-6.
    View in: PubMed
    Score: 0.209
  4. Risk of underlying chronic medical conditions for invasive pneumococcal disease in adults. Vaccine. 2016 08 05; 34(36):4293-7.
    View in: PubMed
    Score: 0.133
  5. Lack of association of Kawasaki disease after immunization in a cohort of infants followed for multiple autoimmune diagnoses in a large, phase-4 observational database safety study of 7-valent pneumococcal conjugate vaccine: lack of association between Kawasaki disease and seven-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2009 May; 28(5):438-40.
    View in: PubMed
    Score: 0.081
  6. Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007 Sep; 26(9):771-7.
    View in: PubMed
    Score: 0.072
  7. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects. Pediatr Infect Dis J. 2006 Jun; 25(6):494-501.
    View in: PubMed
    Score: 0.066
  8. Pneumococcal conjugate vaccine in children. N Engl J Med. 2004 Jan 01; 350(1):84-5; author reply 84-5.
    View in: PubMed
    Score: 0.056
  9. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000 Mar; 19(3):187-95.
    View in: PubMed
    Score: 0.043
  10. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J. 2002 Mar; 21(3):182-6.
    View in: PubMed
    Score: 0.012
  11. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J. 1999 Sep; 18(9):757-63.
    View in: PubMed
    Score: 0.010

© 2024 Kaiser Permanente